| The systemic amyloidoses RH Falk, RL Comenzo, M Skinner New England Journal of Medicine 337 (13), 898-909, 1997 | 1608 | 1997 |
| Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International … MA Gertz, R Comenzo, RH Falk, JP Fermand, BP Hazenberg, ... American journal of hematology 79 (4), 319-328, 2005 | 1535 | 2005 |
| International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders A Dispenzieri, R Kyle, G Merlini, JS Miguel, H Ludwig, R Hájek, ... Leukemia 23 (2), 215-224, 2009 | 1036 | 2009 |
| New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes G Palladini, A Dispenzieri, MA Gertz, S Kumar, A Wechalekar, ... J Clin Oncol 30 (36), 4541-4549, 2012 | 930 | 2012 |
| Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation BGM Durie, RA Kyle, A Belch, W Bensinger, J Blade, M Boccadoro, ... The Hematology Journal 4 (6), 379-398, 2003 | 622 | 2003 |
| Oral selinexor–dexamethasone for triple-class refractory multiple myeloma A Chari, DT Vogl, M Gavriatopoulou, AK Nooka, AJ Yee, CA Huff, ... New England Journal of Medicine 381 (8), 727-738, 2019 | 597 | 2019 |
| Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group MA Dimopoulos, E Terpos, A Chanan-Khan, N Leung, H Ludwig, ... Journal of clinical oncology 28 (33), 4976-4984, 2010 | 534 | 2010 |
| Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma A Chari, A Suvannasankha, JW Fay, B Arnulf, JL Kaufman, ... Blood, The Journal of the American Society of Hematology 130 (8), 974-981, 2017 | 496 | 2017 |
| Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis MS Maurer, P Elliott, R Comenzo, M Semigran, C Rapezzi Circulation 135 (14), 1357-1377, 2017 | 462 | 2017 |
| Autologous stem cell transplantation for primary systemic amyloidosis RL Comenzo, MA Gertz Blood, The Journal of the American Society of Hematology 99 (12), 4276-4282, 2002 | 446 | 2002 |
| International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment MA Dimopoulos, P Sonneveld, N Leung, G Merlini, H Ludwig, E Kastritis, ... Journal of Clinical Oncology 34 (13), 1544-1557, 2016 | 436 | 2016 |
| Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis RL Comenzo, D Reece, G Palladini, D Seldin, V Sanchorawala, ... Leukemia 26 (11), 2317-2325, 2012 | 421 | 2012 |
| Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group C Fernández de Larrea, RA Kyle, BGM Durie, H Ludwig, S Usmani, ... Leukemia 27 (4), 780-791, 2013 | 411 | 2013 |
| Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients RL Comenzo, E Vosburgh, RH Falk, V Sanchorawala, J Reisinger, ... Blood, The Journal of the American Society of Hematology 91 (10), 3662-3670, 1998 | 411 | 1998 |
| International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma M Dimopoulos, E Terpos, RL Comenzo, P Tosi, M Beksac, O Sezer, ... Leukemia 23 (9), 1545-1556, 2009 | 401 | 2009 |
| Daratumumab-based treatment for immunoglobulin light-chain amyloidosis E Kastritis, G Palladini, MC Minnema, AD Wechalekar, A Jaccard, HC Lee, ... New England Journal of Medicine 385 (1), 46-58, 2021 | 358 | 2021 |
| Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102 … A Krishnan, MC Pasquini, B Logan, EA Stadtmauer, DH Vesole, E Alyea, ... The lancet oncology 12 (13), 1195-1203, 2011 | 332 | 2011 |
| The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig VL germ line gene use and clonal plasma cell burden RL Comenzo, Y Zhang, C Martinez, K Osman, GA Herrera Blood, The Journal of the American Society of Hematology 98 (3), 714-720, 2001 | 322 | 2001 |
| Management of treatment-emergent peripheral neuropathy in multiple myeloma PG Richardson, M Delforge, M Beksaç, P Wen, JL Jongen, O Sezer, ... Leukemia 26 (4), 595-608, 2012 | 310 | 2012 |
| New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG) EM Ocio, PG Richardson, SV Rajkumar, A Palumbo, MV Mateos, ... Leukemia 28 (3), 525-542, 2014 | 306 | 2014 |
